Stage IIIA Cervical Cancer

9 clinical trials · Condition

Record	Firm	Date
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners (NCT03112668)	Rutgers, The State University of New Jersey	2017-12-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations (NCT02646319)	Mayo Clinic	2016-01-01
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors (NCT03198286)	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	2015-08-01
MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer (NCT01992861)	University of Washington	2014-02-14
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520)	City of Hope Medical Center	2013-10-01
Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer (NCT01676818)	University of Southern California	2012-08-09
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer (NCT01764802)	Ohio State University Comprehensive Cancer Center	2010-10-01
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery (NCT01026792)	National Cancer Institute (NCI)	2009-12-01
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies (NCT00335998)	National Cancer Institute (NCI)	2006-03-01

Track Stage IIIA Cervical Cancer automatically

Every clearance here is in the API, with alerts when new ones post.